Staff Reporter

Zimbabwe’s pharmaceutical manufacturing industry is on the brink of a significant transformation, driven by strategic policy recommendations and a commitment to boosting local production.

A well-placed source within the Ministry of Industry and Commerce has disclosed that the Pharmaceutical Manufacturing Association (PMA) is advocating for a full import restriction on medicines that can be produced domestically.

 “The decline in market share highlights the immense potential for growth in our local pharmaceutical industry. By implementing strategic import restrictions, we can empower local manufacturers to increase their production capacity and improve market competitiveness,” the source noted

The source further emphasized the positive impacts of nurturing local production capabilities.

 “With proper support, Zimbabwe’s pharmaceutical manufacturers can modernize their facilities, adopt advanced technologies, and expand their workforce. What we need now are the right policies to create an enabling environment for growth,” said the source.

The PMA’s proposal to limit imports is seen as a forward-thinking strategy to foster self-sufficiency. By prioritizing domestically produced medicines, Zimbabwe can stimulate industrial growth, attract investment, and build a robust supply chain.

“Restricting imports is a strategic move to boost our local industry. It’s about creating a sustainable pharmaceutical sector that can meet domestic demand and compete internationally,” explained the source

Source expressed optimism about the future of Zimbabwe’s pharmaceutical industry, highlighting ongoing efforts to provide financial support and incentives to local manufacturers.

“We are committed to supporting our local manufacturers. These initiatives are designed to reduce production costs, upgrade technology, and enhance the overall quality of locally made medicines. With the right investments and policy frameworks, we can transform our pharmaceutical sector into a pillar of economic growth,” the source added

Meanwhile, as the Second Republic moves forward with its NDS1 goals, the revitalization of the pharmaceutical manufacturing sector will play a pivotal role. The country’s ability to produce its own medicines not only strengthens its economy but also ensures a healthier future for its citizens.